Indian Pharmaceuticals Alliance
- All
- News
- Videos
-
Budget 2023: What Pharma Industry Is Expecting
The budget should outline supportive policies, simplified regulations, and simple GST norms to aid in the development of the pharmaceutical industry, Indian Pharmaceutical Alliance (IPA) Secretary General Sudarshan Jain said.
-
Budget 2022: Pharma Sector Seeks Greater Fund Allocation
The pharma industry is expecting an increase in the overall fund allocation for the healthcare sector, focus on policies that encourage R&D activities
-
Indian Pharma Eyes Pride Of Place, Regulation Achilles Heel
The $32-billion generic-driven Indian pharma industry is eyeing a sea of opportunities as global demand for safe and quality drugs rises.
-
Like Corex, Cough Syrup Phensedyl Is Banned, Makers Will Go To Court
The Delhi High Court has said that for now, a government ban on popular cough syrup Corex, made by US pharma Pfizer, will not hold. The court will next hear the case on Monday.
-
Customs Duty Move May Cause Drug Price Hike: Industry
Government's move will adversely impact patients' interest, say experts.
-
India Adds More Cancer, HIV/AIDS Drugs To Essential Medicines List
The government has revised its list of essential medicines to add drugs for diseases ranging from cancer and HIV/AIDS to hepatitis C, in a move aimed at making them more affordable.
-
Register With Online Database: Drug Pricing Regulator to Firms
With 32 of top 100 pharmaceutical firms not responding to its direction to register for online database, the National Pharmaceutical Pricing Authority (NPPA) has asked pharma associations to ask their members to register immediately.
-
Price Controls: Pharma Industry Favours Dialogue With Government, Says Report
After failing to get a stay order from the Delhi High Court on the latest round of drug price control order, the pharmaceuticals industry has called for a dialogue with the regulators to resolve the row, saying such issues are best ironed out through dialogues than in court rooms.
-
Drug prices, takeover of domestic firms remain government focus in 2012
A new drug price control policy at long last, restrictions on multinationals taking over domestic firms and India cracking down on foreign firms' patents marked the year 2012 for the country's $22 billion pharmaceutical sector.
-
New drug policy will hurt investment in pharma sector: Industry
Prices of various leading drug brands will come down by up to 80 per cent thanks to the newly-approved National Pharmaceutical Pricing Policy but at the same time it will hurt investment sentiments in the country's pharmaceutical sector, according to industry bodies.
-
Budget 2023: What Pharma Industry Is Expecting
The budget should outline supportive policies, simplified regulations, and simple GST norms to aid in the development of the pharmaceutical industry, Indian Pharmaceutical Alliance (IPA) Secretary General Sudarshan Jain said.
-
Budget 2022: Pharma Sector Seeks Greater Fund Allocation
The pharma industry is expecting an increase in the overall fund allocation for the healthcare sector, focus on policies that encourage R&D activities
-
Indian Pharma Eyes Pride Of Place, Regulation Achilles Heel
The $32-billion generic-driven Indian pharma industry is eyeing a sea of opportunities as global demand for safe and quality drugs rises.
-
Like Corex, Cough Syrup Phensedyl Is Banned, Makers Will Go To Court
The Delhi High Court has said that for now, a government ban on popular cough syrup Corex, made by US pharma Pfizer, will not hold. The court will next hear the case on Monday.
-
Customs Duty Move May Cause Drug Price Hike: Industry
Government's move will adversely impact patients' interest, say experts.
-
India Adds More Cancer, HIV/AIDS Drugs To Essential Medicines List
The government has revised its list of essential medicines to add drugs for diseases ranging from cancer and HIV/AIDS to hepatitis C, in a move aimed at making them more affordable.
-
Register With Online Database: Drug Pricing Regulator to Firms
With 32 of top 100 pharmaceutical firms not responding to its direction to register for online database, the National Pharmaceutical Pricing Authority (NPPA) has asked pharma associations to ask their members to register immediately.
-
Price Controls: Pharma Industry Favours Dialogue With Government, Says Report
After failing to get a stay order from the Delhi High Court on the latest round of drug price control order, the pharmaceuticals industry has called for a dialogue with the regulators to resolve the row, saying such issues are best ironed out through dialogues than in court rooms.
-
Drug prices, takeover of domestic firms remain government focus in 2012
A new drug price control policy at long last, restrictions on multinationals taking over domestic firms and India cracking down on foreign firms' patents marked the year 2012 for the country's $22 billion pharmaceutical sector.
-
New drug policy will hurt investment in pharma sector: Industry
Prices of various leading drug brands will come down by up to 80 per cent thanks to the newly-approved National Pharmaceutical Pricing Policy but at the same time it will hurt investment sentiments in the country's pharmaceutical sector, according to industry bodies.
